MTP News and Press, Midatech Pharma PLC From 06/01/22

The ADRs of U.K.-based biotech Midatech Pharma (NASDAQ:MTP) added ~50% in the pre-market Wednesday after the company announced that the FDA issued the Fast Track designation for its development program of MTX110 in recurrent glioblastoma ("rGBM"). A rapidly growing and aggressive br...

Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent Glioblastoma ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 1, 2022 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution...

ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP) , a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces its audited preliminary results for the year ended 31 December 2021. 2021 HIGHLI...

Midatech Pharma (NASDAQ:MTP) received a letter from the Listings Qualifications Department of the Nasdaq that it is not in compliance with the minimum bid price. The notification does not lead to immediate delisting of shares. It has a compliance period of 180 calendar days, or unti...

ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce an extension of its existing R&D collaboration with Janssen Pharmaceut...

ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine, is pleased to announce the appointment of Strand Hanson Limited as the Company's Nominated and Fin...

Gainers: Palisade Bio (NASDAQ:PALI) +23%. Pharming Group (NASDAQ:PHAR) +14%. Entasis Therapeutics (NASDAQ:ETTX) +13%. Epizyme (NASDAQ:EPZM) +11%. IceCure Medical (NASDAQ:ICCM) +10%. Losers: LogicBio Therapeutics (NASDAQ:LOGC) -50%. Pardes Bios...

Arena Pharmaceuticals (NASDAQ:ARNA) +90% on acquisition by Pfizer. Foghorn Therapeutics (NASDAQ:FHTX) +38% after collaborating with Lilly in oncology medicines. BELLUS Health (NASDAQ:BLU) +36% on positive BLU-5937 data in mid-stage chronic cough study. Petros Pha...

Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13, 2021 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bi...

Midatech Pharma plc (MTP) Q2 2021 Earnings Conference Call September 20, 2021, 12:30 PM ET Company Participants Tim Metcalfe - MD, IFC Advisory Limited, IR Stephen Stamp - CEO & CFO Conference Call Participants Presentation Tim Metcalfe Well, it seems like most people are with us now. So ...